Vanda Pharmaceuticals (VNDA) Share-based Compensation Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.70% |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | -13.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.73% |
| Dec 31, 2025 | -20.19% |
| Sep 30, 2025 | -29.58% |
| Jun 30, 2025 | -29.47% |
| Mar 31, 2025 | -17.10% |
| Dec 31, 2024 | -12.53% |
| Sep 30, 2024 | -5.30% |
| Jun 30, 2024 | -8.09% |
| Mar 31, 2024 | -17.63% |
| Dec 31, 2023 | -13.48% |
| Sep 30, 2023 | -18.54% |
| Jun 30, 2023 | -15.17% |
| Mar 31, 2023 | -8.94% |
| Dec 31, 2022 | 0.24% |
| Sep 30, 2022 | -1.59% |
| Jun 30, 2022 | 2.41% |
| Mar 31, 2022 | 22.23% |
| Dec 31, 2021 | 17.50% |
| Sep 30, 2021 | 26.03% |
| Jun 30, 2021 | 21.86% |
| Mar 31, 2021 | -0.89% |
| Dec 31, 2020 | -12.43% |
| Sep 30, 2020 | -7.98% |
| Jun 30, 2020 | -1.03% |
| Mar 31, 2020 | 20.17% |
| Dec 31, 2019 | 25.53% |
| Sep 30, 2019 | 18.63% |
| Jun 30, 2019 | 13.97% |
| Mar 31, 2019 | 4.16% |
| Dec 31, 2018 | 5.03% |
| Sep 30, 2018 | 3.64% |
| Jun 30, 2018 | 2.45% |
| Mar 31, 2018 | 39.67% |
| Dec 31, 2017 | 32.29% |
| Sep 30, 2017 | 31.95% |
| Jun 30, 2017 | 28.06% |
| Mar 31, 2017 | -0.44% |
| Dec 31, 2016 | 11.45% |
| Sep 30, 2016 | 1.89% |
| Jun 30, 2016 | 0.29% |
| Mar 31, 2016 | 16.50% |
| Dec 31, 2015 | 15.70% |
| Sep 30, 2015 | 46.07% |
| Jun 30, 2015 | 43.31% |
| Mar 31, 2015 | 39.63% |
| Dec 31, 2014 | 11.94% |
| Sep 30, 2014 | -8.14% |
| Jun 30, 2014 | 30.35% |
| Mar 31, 2014 | 6.83% |
| Dec 31, 2013 | -22.33% |
| Sep 30, 2013 | 166.67% |
| Jun 30, 2013 | -6.82% |
| Mar 31, 2013 | -6.25% |
| Dec 31, 2012 | 42.34% |
| Sep 30, 2012 | -54.07% |
| Jun 30, 2012 | -10.34% |
| Mar 31, 2012 | -13.28% |
| Dec 31, 2011 | -1.27% |
| Sep 30, 2011 | 41.38% |